Publication | Closed Access
Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial
210
Citations
21
References
2008
Year
Adalimumab maintenance therapy provided sustained improvements in HRQOL for patients with moderate to severe Crohn's disease through week 56.
| Year | Citations | |
|---|---|---|
Page 1
Page 1